Deep Vein Thrombosis Research Today is a free monthly online journal that collates and summarizes the latest research about Deep Vein Thrombosis, including details on dvt, prevention, effects, causes, air travel, blood clots.

Volume 4 (2007), Issue 4 (April)

1. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
   Ophthalmology, 114(4): 716-23. [Abstract] [Full-text]
2. Vena cava filters and inferior vena cava thrombosis.
   J Vasc Surg, 45(4): 789-94. [Abstract] [Full-text]
3. Safety, feasibility, and outcome of retrievable vena cava filters in high-risk surgical patients.
   J Vasc Surg, 45(4): 784-8; discussion 788. [Abstract] [Full-text]
4. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients.
   J Vasc Surg, 45(4): 776-83. [Abstract] [Full-text]
5. Prevention of venous thromboembolism in surgical patients with breast cancer.
   Br J Surg, 94(4): 412-20. [Abstract] [Full-text]
6. Outcome of pulmonary function in Lemierre's disease-associated acute respiratory distress syndrome.
   Pediatr Pulmonol, 42(4): 389-92. [Abstract] [Full-text]
7. Endovenous laser treatment of the small [corrected] saphenous vein: efficacy and complications.
   J Vasc Surg, 45(4): 795-801; discussion 801-3. [Abstract] [Full-text]
8. High incidence of venous thromboembolic events in lung transplant recipients.
   J Heart Lung Transplant, 26(4): 339-44. [Abstract] [Full-text]
9. Minimizing costs for treating deep vein thrombosis: the role for fondaparinux.
   J Thromb Thrombolysis, 23(3): 229-36. [Abstract] [Full-text]
10. Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics.
    J Pediatr Hematol Oncol, 29(4): 269-73. [Abstract] [Full-text]
11. Relapsing splenic vein thrombosis associated with antiphospholipid antibodies in a patient with wegener granulomatosis.
    J Clin Rheumatol, 13(2): 92-3. [Abstract] [Full-text]
12. Diagnostic value of D-dimer in outpatients with suspected deep venous thrombosis receiving oral anticoagulation.
    Blood Coagul Fibrinolysis, 18(3): 253-7. [Abstract] [Full-text]
13. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease.
    J Cardiovasc Med (Hagerstown), 8(4): 253-7. [Abstract] [Full-text]
14. Myocardial infarction and venous thrombosis in a 42-year old woman with heterozygous methylenetetrahydrofolate reductase (MTHRF) gene mutation, hyperhomocysteinemia, and protein C deficiency.
    Int J Cardiol, 117(3): e98-100. [Abstract] [Full-text]
15. Central retinal venous occlusion in an otherwise-healthy child.
    J AAPOS, 11(2): 189-91. [Abstract] [Full-text]
16. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease.
    Retina, 27(4): 426-31. [Abstract] [Full-text]
17. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.
    Retina, 27(4): 419-25. [Abstract] [Full-text]
18. Drug delivery methods for posterior segment disease.
    Curr Opin Ophthalmol, 18(3): 235-9. [Abstract] [Full-text]
19. Sex hormones and thrombosis.
    Semin Hematol, 44(2): 98-105. [Abstract] [Full-text]
20. Predictive genetic variants for venous thrombosis: what's new?
    Semin Hematol, 44(2): 85-92. [Abstract] [Full-text]
21. Plasma coagulation factor levels in venous thrombosis.
    Semin Hematol, 44(2): 77-84. [Abstract] [Full-text]
22. Hyperhomocysteinemia and venous thrombosis.
    Semin Hematol, 44(2): 70-6. [Abstract] [Full-text]
23. Epidemiology and risk factors for venous thrombosis.
    Semin Hematol, 44(2): 62-9. [Abstract] [Full-text]
24. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
    Ann Pharmacother, 41(4): 635-41. [Abstract] [Full-text]
25. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
26. Treatment for superficial thrombophlebitis of the leg.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
27. Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.
    Int J Clin Oncol, 12(2): 150-4. [Abstract] [Full-text]
28. Ultrasound in the detection of venous thromboembolism.
    Crit Care Med, 35(5): S224-34. [Abstract] [Full-text]
29. Clinical comparison of two optional vena cava filters.
    J Vasc Interv Radiol, 18(4): 505-11. [Abstract] [Full-text]
30. The etiologic distribution of thrombophilic factors in chronic portal vein thrombosis.
    J Clin Gastroenterol, 41(5): 521-7. [Abstract] [Full-text]
31. Enhancing and expansile portal vein thrombosis: value in the diagnosis of hepatocellular carcinoma in patients with multiple hepatic lesions.
    AJR Am J Roentgenol, 188(5): 1320-3. [Abstract] [Full-text]
32. Power-pulse spray thrombectomy for treatment of Paget-Schroetter syndrome.
    AJR Am J Roentgenol, 188(5): 1215-7. [Abstract] [Full-text]
33. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Int J Surg, 5(2): 114-9. [Abstract] [Full-text]
34. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.
    Lancet, 369(9570): 1347-55. [Abstract] [Full-text]
35. Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer.
    Gynecol Oncol, 105(2): 414-7. [Abstract] [Full-text]
36. Skull bone infarctive crisis and deep vein thrombosis in homozygous sickle cell disease- case report and review of the literature.
    Hematology, 12(2): 169-74. [Abstract] [Full-text]
37. Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent.
    Stroke, 38(5): 1476-81. [Abstract] [Full-text]
38. Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapy.
    Clin Appl Thromb Hemost, 13(2): 161-5. [Abstract] [Full-text]
39. The quality of oral anticoagulant therapy and recurrent venous thrombotic events in the Leiden Thrombophilia Study.
    J Thromb Haemost, 5(5): 931-6. [Abstract] [Full-text]
40. Venous thromboembolic disease in the elderly patient: atypical, subtle, and enigmatic.
    Clin Geriatr Med, 23(2): 413-23, viii. [Abstract] [Full-text]
41. Proximate versus nonproximate risk factor associated primary deep venous thrombosis: clinical spectrum and outcomes.
    J Vasc Surg, 45(5): 998-1003; discussion 1003-4; quiz 1005-7. [Abstract] [Full-text]
42. Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement.
    J Vasc Surg, 45(5): 992-7; discussion 997. [Abstract] [Full-text]
43. Interventions for branch retinal vein occlusion: an evidence-based systematic review.
    Ophthalmology, 114(5): 835-54. [Abstract] [Full-text]

© 2004-2008 Deep Vein Thrombosis Research Today. All Rights Reserved.